These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16302958

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH.
    Ookoshi T, Hasegawa K, Ohhashi Y, Kimura H, Takahashi N, Yoshida H, Miyazaki R, Goto Y, Naiki H.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373
    [Abstract] [Full Text] [Related]

  • 43. Amyloids: not only pathological agents but also ordered nanomaterials.
    Cherny I, Gazit E.
    Angew Chem Int Ed Engl; 2008 Oct; 47(22):4062-9. PubMed ID: 18412209
    [Abstract] [Full Text] [Related]

  • 44. Amyloid fibril formation by a domain of rat cell adhesion molecule.
    Carroll A, Yang W, Ye Y, Simmons R, Yang JJ.
    Cell Biochem Biophys; 2006 Oct; 44(2):241-9. PubMed ID: 16456226
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
    Sun X, Ueda M, Yamashita T, Nakamura M, Bergström J, Zeledon Ramirez ME, Okajima M, Misumi S, Shoji S, Motomiya Y, Ando Y.
    Amyloid; 2006 Mar; 13(1):20-3. PubMed ID: 16690496
    [Abstract] [Full Text] [Related]

  • 51. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y, Ueda M, Fujimori H, Shinriki S, Meng W, Kim J, Saito S, Obayashi K, Uchino M, Ando Y.
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease.
    Lansbury PT.
    Proc Natl Acad Sci U S A; 1999 Mar 30; 96(7):3342-4. PubMed ID: 10097040
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The nature and origin of amyloid fibrils. Proceedings of a symposium. Oeiras, Portugal, 23-25 October 1995.
    Ciba Found Symp; 1996 Mar 30; 199():1-253. PubMed ID: 8915600
    [No Abstract] [Full Text] [Related]

  • 56. Protein folding: The dark side of proteins.
    Schnabel J.
    Nature; 2010 Apr 08; 464(7290):828-9. PubMed ID: 20376124
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Amyloidosis.
    Varga J.
    J Med Soc N J; 1984 Mar 08; 81(3):248. PubMed ID: 6585571
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Conformational diseases.
    Zatta P.
    Curr Alzheimer Res; 2008 Dec 08; 5(6):499. PubMed ID: 19075575
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.